Pamiparib in mCRPC With HRD or BRCA1/2 Mutation

Clinical trial NCT05327621 · UNKNOWN

Trial details

NCT number: NCT05327621
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2022-05-01
Primary completion: 2025-03-20
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.